Ensuring informed consent is properly obtained is a legal, ethical and professional requirement on the part of all treating health professionals and supports person-centred care.
Found 697 result(s)
To ensure that AHPEQS can be a meaningful tool for quality and safety improvement and person-centred care, you need to first think carefully about how you want to use the survey and why. You also need to consider how AHPEQS can be best used in your organisation, given your existing patient experience work and contextual constraints and enablers.
The Chronic Obstructive Pulmonary Disease Clinical Care Standard provides guidance to clinicians and healthcare services on managing chronic obstructive pulmonary disease. The standard was released on 17 October 2024.
The Australian Hospital Patient Experience Question Set (AHPEQS) is a survey used by hospitals and healthcare services to ask recent patients about their experiences of treatment and care.
Leaders of a health service organisation describe, implement and monitor systems to ensure the safe, appropriate, efficient and effective care of patients’ own blood, as well as other blood and blood products. The workforce uses the blood product safety systems.
The Commission has drafted the Environmental Sustainability and Climate Resilience Healthcare Module as a framework of actions that health services can use to ensure their services are improving the safety and quality of care while addressing the health impacts of climate change and healthcare’s contribution to climate change.
There are four major steps when preparing for an assessment which include:
- Getting to know the NSQHS Standards
- Allocating resources and coordinating implementation
- Selecting an accrediting agency
- Conducting a self-assessment and gathering evidence.
This page includes links to Australian and international resources to support antimicrobial stewardship (AMS) programs in health service organisations and in aged care and primary care. AMS programs help to improve patient safety and in the prevention and control of antimicrobial resistance (AMR).
Effective clinical communication is two-way (or multi-way if between teams), structured and continuous communication that results in timely, accurate and appropriate transfer of information.
For communication to be effective it needs to be tailored, open, honest, and respectful, with opportunities for clarification and feedback.
The Commission’s Antimicrobial Use and Resistance in Australia (AURA) Project contributes to the national program for surveillance of antimicrobial use and resistance in human health across Australia.
The Commission understands its role as a data custodian of primary healthcare data and is committed to ensuring it is managed in a manner which is consistent with the requirements of relevant state and territory laws and standards. We extract non-identifiable, unit-level data from participating general practice systems. Non-identifiable data is the output of the de-identification process, which involves the removal or alteration of information that identifies a person, or is reasonably likely to identify them, as well the application of any additional protections to prevent identification; including re-identification risks.
The Hip Fracture Clinical Care Standard contains seven quality statements describing the care that should be offered to patients with a suspected hip fracture from presentation to hospital through to completion of treatment in hospital.
This standard applies to care provided in all hospital settings, including public and private hospitals and subacute facilities.
Short notice assessment for accreditation to the NSQHS Standards, ensures the outcome reflects day to day practices, identifies gaps and supports health service organisations to improve safety and quality systems and processes.
The National Medicines Symposium 2024, was held on the 19 November and explored the safe and appropriate use of medications in an ageing population.
From 1 January 2023, the Australian Commission on Safety and Quality in Health Care (the Commission) became the custodian of a range of Quality Use of Medicines (QUM) functions, expanding our role in QUM stewardship. This follows the redesign of the Quality Use of Diagnostics, Therapeutics and Pathology (QUDTP) Program outlined in the 2022–23 Federal Budget.
Status updates for each function can be found below.
On 30 June 2021, the Department of Prime Minister and Cabinet (PM&C) released the Regulator Performance Guide (the Guide), which seeks to increase accountability, promote best practice, build professionalism and support cultural change among regulators.